Freedom Investment Management’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-54,735
| Closed | -$135K | – | 929 |
|
|
2020
Q4 | $135K | Sell |
54,735
-14,674
| -21% | -$35.7K | 0.01% | 590 |
|
|
2020
Q3 | $219K | Sell |
69,409
-10,181
| -13% | -$32.5K | 0.02% | 486 |
|
|
2020
Q2 | $232K | Sell |
79,590
-6,919
| -8% | -$21.9K | 0.03% | 475 |
|
|
2020
Q1 | $304K | Buy |
86,509
+651
| +0.8% | +$2.1K | 0.03% | 491 |
|
|
2019
Q4 | $279K | Sell |
85,858
-8,017
| -9% | -$23.3K | 0.02% | 508 |
|
|
2019
Q3 | $203K | Sell |
93,875
-15,275
| -14% | -$40.8K | 0.02% | 636 |
|
|
2019
Q2 | $343K | Sell |
109,150
-12,334
| -10% | -$40K | 0.03% | 477 |
|
|
2019
Q1 | $452K | Buy |
121,484
+2,228
| +2% | +$7.52K | 0.04% | 403 |
|
|
2018
Q4 | $346K | Sell |
119,256
-8,248
| -6% | -$22.7K | 0.03% | 525 |
|
|
2018
Q3 | $306K | Buy |
127,504
+3,302
| +3% | +$8.1K | 0.02% | 695 |
|
|
2018
Q2 | $291K | Sell |
124,202
-98,752
| -44% | -$276K | 0.02% | 769 |
|
|
2018
Q1 | $655K | Buy |
222,954
+1,268
| +0.6% | +$3.46K | 0.03% | 516 |
|
|
2017
Q4 | $607K | Buy |
221,686
+4,109
| +2% | +$12.6K | 0.03% | 547 |
|
|
2017
Q3 | $738K | Sell |
217,577
-15,356
| -7% | -$42.7K | 0.04% | 451 |
|
|
2017
Q2 | $575K | Buy |
232,933
+1,125
| +0.5% | +$2.59K | 0.03% | 511 |
|
|
2017
Q1 | $526K | Sell |
231,808
-30,501
| -12% | -$67.5K | 0.03% | 527 |
|
|
2016
Q4 | $556K | Sell |
262,309
-73,455
| -22% | -$205K | 0.03% | 447 |
|
|
2016
Q3 | $1.13M | Sell |
335,764
-12,161
| -3% | -$38.6K | 0.07% | 212 |
|
|
2016
Q2 | $1.09M | Buy |
347,925
+22,133
| +7% | +$73.8K | 0.07% | 201 |
|
|
2016
Q1 | $1.08M | Buy |
325,792
+46,107
| +16% | +$144K | 0.08% | 191 |
|
|
2015
Q4 | $990K | Buy |
279,685
+279,158
| +52,971% | +$1.17M | 0.08% | 219 |
|
|
2015
Q3 | $652K | Sell |
527
-177,999
| -100% | -$1.02M | 0.07% | 254 |
|
|
2015
Q2 | $1.15M | Buy |
178,526
+55,825
| +45% | +$374K | 0.12% | 133 |
|
|
2015
Q1 | $864K | Buy |
122,701
+62,752
| +105% | +$454K | 0.1% | 170 |
|
|
2014
Q4 | $462K | Buy |
59,949
+35,019
| +140% | +$277K | 0.06% | 307 |
|
|
2014
Q3 | $186K | Buy |
+24,930
| New | +$231K | 0.03% | 457 |
|
Other funds holding PDLI
Freedom Investment Management's PDLI Position: Q1 2021 in Review
Freedom Investment Management sold out of PDL BioPharma, Inc. (PDLI) in Q1 2021, closing a stake of 54,735 shares — an estimated $135K sold.
Freedom Investment Management first reported a position in PDLI in Q3 2014 and held it in 26 quarters. The position peaked at $1.15M in Q2 2015. 11 funds tracked by Wall St. Rank hold PDLI as of Q1 2021.
- Freedom Investment Management reported no remaining PDL BioPharma, Inc. position as of Q1 2021 after selling out during the quarter.
- Freedom Investment Management sold 54,735 PDL BioPharma, Inc. shares in Q1 2021, an estimated $135K.
- Freedom Investment Management first reported a position in PDL BioPharma, Inc. in Q3 2014 and held it in 26 quarters.
- Freedom Investment Management's PDL BioPharma, Inc. position peaked at $1.15M in Q2 2015.
- 11 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2021.
Based on Freedom Investment Management's 13F filing for Q1 2021, filed 14 May 2021.